StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis USD-Denominated Long-Term Debt (Form 20-F) by Year

USD-Denominated Long-Term Debt (Form 20-F) ($M)

Novartis USD-Denominated Long-Term Debt (Form 20-F): $18,778M in FY2025, up 21.2% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
18,778
Period ended Dec 31, 2025
Change on a year earlier
+21.2%
15,495 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Reported in Form 20-F Note 19.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUSD-Denominated Long-Term Debt (Form 20-F) ($M)Year on yearSource
FY2025Dec 31, 202518,778+21.2%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 202415,495+15.7%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 202313,388+0.1%Novartis Form 20-F (0001370368-25-000004) ↗
FY2022Dec 31, 202213,376-15.7%Novartis Form 20-F (0001370368-24-000004) ↗
FY2021Dec 31, 202115,862+0.1%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2020Dec 31, 202015,848+23.0%Novartis Form 20-F (0001370368-22-000010) ↗
FY2019Dec 31, 201912,889-19.3%Novartis Form 20-F (0001370368-21-000006) ↗
FY2018Dec 31, 201815,964+0.1%Novartis Form 20-F (0001370368-20-000003) ↗
FY2017Dec 31, 201715,945–Novartis Form 20-F (0001370368-19-000002) ↗

Cite this data

StockData. (2026). Novartis USD-Denominated Long-Term Debt (Form 20-F) ($M), annual FY2017–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/debt-by-currency-usd

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.